Exhibit 10.1
AMENDMENT TO
SUBORDINATED LOAN NOTE
By this Allonge (this "ALLONGE"), to the Subordinated Loan Note dated as
of May 18, 1999 by the undersigned Borrowers in favor of Fresenius AG, a German
corporation, in the maximum principal amount of $400,000,000 (the "NOTE") the
Borrowers and the Lender hereby agree as follows:
1. All capitalized terms used herein without definition shall have the
meanings assigned thereto in the Note.
2. The reference to "September 30, 2003" in paragraph 2 of the Note is
amended and replaced by a reference to "October 31, 2007".
3. All references to the NMC Credit Agreement shall mean and include a
reference to the Amended and Restated Credit Agreement dated as of February 21,
2003 among FMC, Fresenius Medical Care Holdings, Inc., the other Borrowers and
Guarantors, identified therein, Bank of America, N.A., as Administrative Agent
and the other agents identified therein, as amended, restated, supplemented or
otherwise modified from time to time (such agreement, as so amended, restated,
supplemented or otherwise modified from time to time, the "AMENDED AND RESTATED
CREDIT AGREEMENT").
4. The pricing matrix set forth in paragraph 4 of the Note was amended as
of the date of the effectiveness of the Amended and Restated Credit Agreement
to reflect the change in pricing under the Amended and Restated Credit
Agreement:
-----------------------------------------------------------------
PRICING LEVEL CONSOLIDATED LEVERAGE RATIO MARGIN
-----------------------------------------------------------------
I =>3.5:1.0 2.00%
-----------------------------------------------------------------
II >3.0:1.0 but <=3:5:1.0 1.75%
-----------------------------------------------------------------
III >2.5:1.0 but <=3.0:1.0 1.50%
-----------------------------------------------------------------
IV >2.0:1.0 but <=2.5:1.0 1.25%
-----------------------------------------------------------------
V <=2.0:1.0 1.00%
-----------------------------------------------------------------
5. The definition of Preferred Indebtedness in paragraph 7 of the Note is
amended to include all "Senior Indebtedness" of any Borrower as defined in any
other Trust Preferred Debt (as defined in the Amended and Restated Credit
Agreement) that is guaranteed by such Borrower or any other debt that is pari
passu thereto that is guaranteed by such Borrower.
6. THE BORROWERS HEREBY COVENANT AND AGREE, AND THE LENDER, BY ITS
ACCEPTANCE HEREOF, HEREBY COVENANTS AND AGREES, THAT, TO THE EXTENT AND IN THE
MANNER HEREINAFTER SET FORTH THE PAYMENT OF THE PRINCIPAL OF THE INDEBTEDNESS
EVIDENCED BY THE NOTE (AS AMENDED HEREBY AND AS IN EFFECT FROM TIME TO TIME)
AND ANY INTEREST PAYABLE IN RESPECT THEREOF ARE HEREBY EXPRESSLY
MADE SUBORDINATE AND SUBJECT IN RIGHT OF PAYMENT TO THE PRIOR PAYMENT IN FULL
OF ALL AMOUNTS THEN DUE AND PAYABLE IN RESPECT OF ALL SENIOR PREFERRED
INDEBTEDNESS.
7. It is hereby further specifically provided that the indebtedness
evidenced by the Note as amended hereby shall rank pari passu with the 7 7/8%
Notes and the 7 3/8% Notes, the other Trust Preferred Subdebt (as defined in
the Amended and Restated Credit Agreement) or any other debt that is pari passu
thereto in right of payment and the obligations (if any) of the Borrowers in
respect thereof, in each case to the extent and only to the extent required by
the terms of such debt; provided, however, that this provision shall not affect
the relative rights (if any) of the holders of the Notes against the Borrowers
other than their rights in relation to the Lender hereunder.
8. To the extent not expressly modified hereby, all provisions of the
Note remain in full force and effect.
9. The Lender hereby releases Lifechem, Inc., as a Borrower.
10.This Allonge, which may be attached to the Note, shall be governed by
and shall be construed and enforced in accordance with the laws of New York
without regard to conflicts of laws principles.
Dated as of September 29, 2003
NATIONAL MEDICAL CARE, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
ALABAMA, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
CONNECTICUT, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
FAYETTEVILLE, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
FLORIDA, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
GEORGIA, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
INDIANA, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
JERSEY CITY, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
KENTUCKY, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
LOUISIANA, LLC (AS SUCCESSOR BY MERGER TO
BIO-MEDICAL APPLICATIONS OF LOUISIANA, INC.)
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
MARYLAND, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
MASSACHUSETTS, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
MISSISSIPPI, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
MISSOURI, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
NEW JERSEY, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
NORTH CAROLINA, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
OHIO, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
OKLAHOMA, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
PENNSYLVANIA, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
SOUTH CAROLINA, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
TEXAS, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
VIRGINIA, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
BIO-MEDICAL APPLICATIONS OF
WISCONSIN, INC.
By: /s/ Xxxx Xxxxxxx
---------------------------------------
Name: Xxxx Xxxxxxx
Title: Treasurer
ACKNOWLEDGED AND AGREED:
FRESENIUS AG
By: /s/ Xxxx Xxxxxx
---------------------------------------
Name: Xxxx Xxxxxx
Title: Senior Vice President Finance
By: /s/ Xx. Xxxxxxx Xxxxxxxxxxx
---------------------------------------
Name: Xx. Xxxxxxx Xxxxxxxxxxx
Title: Treasurer
